Page last updated: 2024-08-23

phenyl acetate and ADDH

phenyl acetate has been researched along with ADDH in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Chang, LS; Chien, SJ; Huang, PY; Huang, YH; Kuo, HC; Wang, LJ; Yang, YH	1
Carr, MM; O'Connell Ferster, AP; Schaefer, E; Schubart, JR	1
Desai, PB; Gabbita, P; Moorthy, G; Sallans, L; Sallee, F; Zemlan, F	1
Ryback, L; Ryback, R	1
Cesena, M; Helmers, SL; Lee, DO; Mikati, MA; Riviello, JJ; Steingard, RJ	1
Bailey, K; Hamrin, V	1

Trials

1 trial(s) available for phenyl acetate and ADDH

Article	Year
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD. Biopharmaceutics & drug disposition, 2015, Volume: 36, Issue:7 Topics: Acetates; Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Betahistine; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Pyridines; Single-Blind Method; Young Adult	2015

Article

Year

Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD.

Biopharmaceutics & drug disposition, 2015, Volume: 36, Issue:7

Topics: Acetates; Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Betahistine; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Pyridines; Single-Blind Method; Young Adult

2015

Other Studies

5 other study(ies) available for phenyl acetate and ADDH

Article	Year
Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study. Journal of the Formosan Medical Association = Taiwan yi zhi, 2021, Volume: 120, Issue:6 Topics: Acetates; Asthma; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Cyclopropanes; Humans; Prospective Studies; Quinolines; Retrospective Studies; Risk Factors; Sulfides; Taiwan	2021
Ancillary medications and outcomes in post-tonsillectomy patients. Ear, nose, & throat journal, 2018, Volume: 97, Issue:8 Topics: Acetates; Adenoidectomy; Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cyclopropanes; Dehydration; Female; Humans; Infant; Male; Outcome Assessment, Health Care; Pain, Postoperative; Postoperative Hemorrhage; Quinolines; Risk Factors; Sulfides; Tonsillectomy	2018
Gabapentin for behavioral dyscontrol. The American journal of psychiatry, 1995, Volume: 152, Issue:9 Topics: Acetates; Adolescent; Amines; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Mental Disorders	1995
Behavioral side effects of gabapentin in children. Epilepsia, 1996, Volume: 37, Issue:1 Topics: Acetates; Aggression; Akathisia, Drug-Induced; Amines; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Child, Preschool; Comorbidity; Cyclohexanecarboxylic Acids; Developmental Disabilities; Dose-Response Relationship, Drug; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male	1996
Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. Journal of child and adolescent psychopharmacology, 2001,Fall, Volume: 11, Issue:3 Topics: Acetates; Amines; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Methylphenidate	2001